Pull 4 Parkinson’s Foundation, Inc., a registered 501(c)(3) public charity,
funds cure and care research conducted by the Parkinson's disease community.
Learn More or Donate.

1193 Parkinson’s Trials Are Completed

Trial Name Last Updated
TREND-HD - A Trial of Ethyl-EPA (Miraxion™) in Treating Mild to Moderate Huntington's Disease 04/26/2018
REGISTRY - an Observational Study of the European Huntington's Disease Network (EHDN) 04/26/2018
An Adult Spasticity Registry of OnabotulinumtoxinA Treatment 04/26/2018
Randomized, Placebo-Controlled Study of AbobotulinumtoxinA (Dysport®) for the Treatment of Cervical Dystonia 04/26/2018
18-Month Study of the Efficacy of Xaliproden (SR57746A) in Patients With Mild-to-Moderate Dementia of the Alzheimer's Type 04/26/2018
An Observational Study of BOTOX® as Headache Prophylaxis for Chronic Migraine 04/26/2018
A Study of RO4602522 in Participants With Moderate Severity Alzheimer Disease on Background Alzheimer Disease Therapy 04/26/2018
EARTH 413: A Study of Aricept in Hispanic Patients With Mild to Moderate Alzheimer's Disease (AD) 04/26/2018
Efficacy and Safety Study of BOTOX® Compared to Topiramate for the Prevention of Chronic Migraine in Adults 04/26/2018
AC-1204 26-Week Long Term Efficacy Response Trial With Optional Open-label Ext 04/26/2018
Dysport® Adult Lower Limb Spasticity Study 04/26/2018
Multiple Ascending Dose Study of Intravenously Administered BMS-986168 in Patients With Progressive Supranuclear Palsy 04/26/2018
Dysport® Adult Upper Limb Spasticity Extension Study 04/26/2018
Dysport® Adult Upper Limb Spasticity 04/26/2018
Tilt-Table Study of the Clinical Efficacy of Midodrine in Symptomatic Orthostatic Hypotension 04/26/2018
Effect of PBT2 in Patients With Early to Mid Stage Huntington Disease 04/26/2018
Phase IV-Cervical Dystonia-INTEREST IN CD2 04/26/2018
Open-label Extension Study of AbobotulinumtoxinA (Dysport®) for the Treatment of Cervical Dystonia 04/26/2018
A Study of Pridopidine (ACR16) for the Treatment of Patients With Huntington's Disease 04/26/2018
Study of a Single Administration of 3 Doses of Dysport® for the Treatment of Benign Essential Blepharospasm 04/26/2018
Risk Factors for Progressive Supranuclear Palsy (PSP) 04/26/2018
Progression Rate of MSA Under EGCG Supplementation as Anti-Aggregation-Approach 04/26/2018

Page 1 of 55 pages  1 2 3 >  Last ›

All ClinicalTrials.gov articles provided courtesy of National Library of Medicine (NLM).